Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome
characterised by persistently activated cytotoxic lymphocytes and macrophages, which, if …

We evaluated malignancy-associated hemophagocytic lymphohistiocytosis (mal-HLH) in
Sweden regarding population-based incidence, clinical features, and survival. From 1997 to …

Hemophagocytic lymphohistiocytosis (HLH) is a rare but often fatal hyperinflammatory
syndrome caused by an inborn or acquired error of immunity. In adults, the underlying …

Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome with
an overall mortality rate of 40%. A multiple-cause-of-death analysis allows for the …

Hemophagocytic lymphohistiocytosis (HLH) is rare, results in high mortality, and is
increasingly being diagnosed. We aimed to quantify the incidence of diagnosed HLH and …

Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially life-threatening
condition caused by excessive immune activation. Secondary HLH is usually triggered by …

Haemophagocytic lymphohistiocytosis (HLH) is a lethal syndrome of excessive immune
activation. We undertook a nationwide study in England of all cases of HLH diagnosed …

Hemophagocytic lymphohistiocytosis (HLH) is a rare potentially life‐threatening condition
characterized by aberrant inflammation that can be related to genetic or sporadic forms. In …

Background Tuberculosis (TB) can induce secondary hemophagocytic lymphohistiocytosis
(HLH), a severe inflammatory syndrome with high mortality. We integrated all published …

Interventions: Aggressive treatment by using combination therapy with immunoglobulins,
intravenous steroids (dexamethasone), cyclosporine, and etoposide was performed …